Microfluidics Market worth $37.2 billion by 2030
The report “Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application [Diagnostics (Clinical, PoC), Research (Proteomics, Genomics, Cell), Therapeutics (Drug Delivery Wearables)], End User – Global forecast to 2030” is projected to grow from USD 24.96 billion in 2025 and to reach USD 37.2 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period.
Browse 150 market data Tables and 100 Figures spread through 345 Pages and in-depth TOC on “Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application [Diagnostics (Clinical, PoC), Research (Proteomics, Genomics, Cell), Therapeutics (Drug Delivery Wearables)], End User – Global forecast to 2030”
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/microfluidics-market-1305.html
The global microfluidics market is projected to reach USD 37.2 billion by 2030 from USD 24.96 billion in 2025, at a CAGR of 8.3% during the forecast period. The growth of this market is driven by the emergence of point-of-care diagnostics, as these devices provide rapid, accurate, and affordable testing in compact designs and are useful in disease detection. Technological advancements in biotechnology, especially genomics, proteomics, and cellular biology, have also increased the adoption levels of microfluidic systems that provide accurate manipulation of fluids at a microscale. Increased use of microfluidics in drug delivery systems is further contributing to the expansion of this market. Additionally, increased expenditure on R&D and key strategies (such as acquisition, collaboration, partnership, product launch, and expansion) adopted by prominent companies support growth. Prominent players like Danaher Corporation (US), Illumina Inc. (US), biomerieux (France), Thermo Fisher Scientific Inc. (US), and Abbott Laboratories (US) are diversifying their product portfolios and participating in acquisitions and collaborations to enhance their market presence.
The microfluidics-based devices segment accounted for the largest market share in 2024.
Microfluidics-based devices account for the largest share of the microfluidics market. These tools decrease the size of analytical and diagnostic procedures, enhancing their efficiency, accuracy, and portability. Their potential to regulate less volume of sample and reagents reduces expenses and less amount of waste is generated, which is beneficial for high-throughput testing in research, diagnostics, and drug discovery laboratories. Additionally, point-of-care testing and medical diagnostics can generate quicker results due to the quick processing times of microfluidics-based devices. Such devices have wide applications in molecular biology, personalized medicine, and lab-on-a-chip systems. Their efficiency is enhanced by their inclusion with innovative technologies like wearables and biosensors.
The in vitro diagnostics segment accounted for the largest market share in 2024.
The increasing demand for faster and accurate point-of-care diagnostics, especially for the diagnosis of genetic abnormalities, cancer, chronic, and infectious diseases, is driving the demand for in vitro diagnostics. Quick and in-the-moment testing can be done with IVD microfluidic devices, which is important for fast decision-making in healthcare settings such as clinics and hospitals. Further, it improves precision and expedites results. A large number of healthcare providers find IVD testing integrated with microfluidic technologies useful, as they are also cost-efficient and resource-efficient.
The hospital and diagnostic center segment is the largest end user of microfluidics.
The large market share for the diagnostic centers segment in the microfluidics market is attributed to the increasing popularity of point-of-care testing and home care testing. Microfluidic devices aid in quick on-site diagnosis with the help of samples in small volumes (in the range of nanoliters (nL) to picoliters (pL)). Quicker and more accurate diagnosis is a feature of this technology, which has application in genetic testing and the detection of infectious diseases. Microfluidic technologies enhance efficiency by offering hospitals and diagnostic centers with optimized processes and a reduction in cost through miniaturization and automation. Microfluidic devices also require minimal chemicals and generate less amount of waste. Hence, diagnostic centers play a significant role in the growth of the microfluidics market.
The US is estimated to account for the largest share of the microfluidics market in North America during the forecast period.
The US dominates the microfluidics market in North America due to its well-developed healthcare system, which raises the requirement for advanced diagnostic tools. The wide application of microfluidics in point-of-care testing and laboratory diagnostics is made possible by this infrastructure. The market growth is also propelled by large investments in pharmaceuticals, healthcare diagnostics, and R&D. The presence of prominent pharmaceutical companies, startups, and academic institutions assists in driving the microfluidic technology. Furthermore, the region's market growth is supported by regulatory settings and government funding & initiatives that support innovative healthcare and advanced technologies such as organ-on-a-chip and lab-on-a-chip.
Key players in this market include Abbott laboratories (US), Agilent Technologies, Inc. (US), Aignep S.P.A (Italy), biomerieux (France), BD (US), Bio-Rad laboratories, Inc. (US), Danaher Corporation (US), Illumina Inc. (US), Parker Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), SMC Corporation (Japan), Idex Corporation (US), Fortive Corporation (US), Perkinelmer, Inc. (US), F.Hoffmann-LA Roche Ltd. (Switzerland), Standard Biotools Inc. (US), Quidelortho Corporation (US), Hologic Inc. (US), Dolomite Microfluidics (UK), and Elveflow (France).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Microfluidics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
